在抗抑郁药治疗之前和之后,患有重度抑郁症的患者进行化
Tina S S Segerberg1, Brice Ozenne2, Vibeke H Dam3
1Neurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Journal of affective disorders
|May 29, 2024
概括
重度抑郁症 (MDD) 的一个关键特征是化,在抗抑郁药物治疗后显著减少. 与没有反应者相比,实现缓解的患者表现出较低的反水平.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 神经科学是一个神经科学.
背景情况:
- 化是严重抑郁症 (MDD) 中对痛苦的不适应反应.
- 在治疗前反和抑郁症严重程度之间的关联,以及其对抗抑郁药物的反应,仍然不清楚.
- 这项研究调查了未经治疗的MDD患者的反和抗抑郁药治疗期间的变化.
研究的目的:
- 评估未经治疗的MDD患者的反和抑郁症严重程度之间的关联.
- 为了探索抗抑郁药治疗开始后的反 levels 的变化.
- 为了在治疗期间比较转发者和不响应者之间的反水平.
主要方法:
- 92名未经治疗的MDD患者使用Rumination Response Scale (RRS) 和使用Hamilton Depression Rating Scale (HDRS) 评估抑郁症严重程度.
- 在抗抑郁药治疗12周之前和之后进行了评估.
- 使用线性回归和混合效应模型来分析数据.
主要成果:
- 治疗前的RRS显示了与抑郁症严重程度的积极关联的趋势 (p=0.06).
- 在开始抗抑郁药治疗后,RRS显著下降 (p<0.0001).
- 与非响应者相比,转发者在4,8和12周的RRS得分明显较低.
结论:
- 虽然治疗前的反与抑郁症状没有显著的相关性,但与抑郁症状的变化密切相关.
- 抗抑郁药物治疗可以缓解MDD患者的反症状.
- 这些发现表明,监测和治疗反动物可能对MDD管理有好处.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
225
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
225
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
370
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
370
01:27Depressive Disorders: MDD and Dysthymia
100
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
100
01:18Depression: Overview
238
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
238
01:25Antidepressant Drugs: Overview
450
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
450
01:54The Placebo Effect
6.1K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.1K